Table 2.
Association of SCNN1G SNPs rs13331086 and blood pressure by inverse variance weighted fixed effects meta-analysis
| Cohort | n | SBP | DBP | ||||
|---|---|---|---|---|---|---|---|
| β | SE | P | β | SE | P | ||
| VFHS | 2876 | 0.81 | 0.46 | 0.01 | 0.37 | 0.29 | 0.58 |
| UPS | 1274 | 0.69 | 0.86 | 0.42 | 1.09 | 0.57 | 0.05 |
| GRAPHIC | 2020 | 1.12 | 0.60 | 0.06 | 0.27 | 0.36 | 0.45 |
| SHS | 583 | 4.25 | 1.74 | 0.02 | 2.53 | 1.00 | 0.04 |
| Meta-Analysis | 6753 | 1.01 | 0.33 | 0.002 | 0.52 | 0.21 | 0.01 |
VFHS, Victorian Family Heart Study; UPS, Utah Pedigree Study; GRAPHIC, Genetic Regulation of Arterial Pressure of Humans in the Community cohort; SHS, Silesian Hypertension Study. SBP, systolic blood pressure; DBP, diastolic blood pressure. Individual population β-coefficients (β), Standard Errors (SE), and P values were obtained from GEE-based association tests for quantitative traits for UPS, GRAPHIC and SHS cohorts and from QTLD analysis for VFHS. Combined β, SE and P were obtained using inverse variance meta-analysis in METAL. All P values were obtained after adjustment for hypertension treatment, age, (and age2, age3, where appropriate), sex and BMI. n- number of subjects with complete genotypic and phenotypic information.